4.125
price down icon11.67%   -0.545
after-market Handel nachbörslich: 4.33 0.205 +4.97%
loading

Finanzdaten der Aldeyra Therapeutics Inc-Aktie (ALDX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Research and Development
20.76%
4.3035
5.4308 8.5052 7.4233 12.44
Operating Income/Loss
16.66%
-6.6679
-8.0011 -10.17 -10.43 -16.14
Nonoperating Income/Loss
34.02%
0.2064
0.3128 0.4014 0.498 1.0246
Income/Loss From Continuing Operations Before Tax
15.96%
-6.4615
-7.6883 -9.7673 -9.9295 -15.11
Income/Loss From Continuing Operations After Tax
15.96%
-6.4615
-7.6883 -9.7673 -9.9295 -15.11
Net Income/Loss
15.96%
-6.4615
-7.6883 -9.7673 -9.9295 -15.11
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.94%
0.0358
60.13 60.05 59.89 59.53
Diluted Average Shares
99.94%
0.0358
60.13 60.05 59.89 59.53
Basic Earnings Per Share
23.08%
-0.10
-0.13 -0.16 -0.17 -0.25
Diluted Earnings Per Share
23.08%
-0.10
-0.13 -0.16 -0.17 -0.25
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):